Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Conditions
- High Risk Cardiovascular Disease
- Hypertension
- High Cardiovascular Risk
Interventions
- DRUG: Zilebesiran
- DRUG: Placebo
Sponsor
Alnylam Pharmaceuticals
Collaborators